Furosemide Market Foreseen to Grow Exponentially by 2027

Furosemide Market – Outline

Furosemide is used to reduce extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, and kidney disease. This can lessen symptoms such as shortness of breath and swelling in your arms, legs, and abdomen. This drug is also used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Furosemide is a “water pill” (diuretic) that causes you to make more urine. This helps your body get rid of extra water and salt.

Read Report Overview –


Furosemide is a loop diuretic medication used to treat fluid build-up due to heart failure, liver scarring, or kidney disease. It may also be used for the treatment of high blood pressure.[1] It can be taken by injection into a vein or by mouth. When taken by mouth, it typically begins working within an hour, while intravenously, it typically begins working within five minutes.

Common side effects include feeling lightheaded with standing, ringing in the ears, and sensitivity to light. Potentially serious side effects include electrolyte abnormalities, low blood pressure, and hearing loss. Blood tests are recommended regularly for those on treatment. Furosemide is a type of loop diuretic that works by decreasing the reabsorption of sodium by the kidneys. Common side effects of furosemide injection include hypokalemia (low potassium level), hypotension (low blood pressure), and dizziness.  Furosemide is primarily used for the treatment of edema, but also in some cases of hypertension (where there is also kidney or heart impairment). It is often viewed as a first-line agent in most people with edema caused by congestive heart failure because of its anti-vasoconstrictor and diuretic effects.

Request Brochure of Report –


Furosemide is a medicine used to decrease the presence of additional liquid in the body that occurs because of illnesses/conditions like coronary illness, kidney infection, and liver sickness. It is additionally utilized for the treatment of hypertension. It is otherwise called diuretic and is basically directed orally or intravenously. The injectable or intravenous structure is utilized when the medication can’t be directed orally, particularly in patients with ongoing infections. The drug assists the kidneys with killing superfluous water and salt from the body through pee. It obstructs the assimilation of sodium, chloride, and water from the liquid in the kidneys. Be that as it may, furosemide conveys many results like drying out, low pulse, and electrolyte exhaustion. The prescription decreases side effects like windedness, and expanding of arms, legs, and stomach.

The commonness of ongoing illnesses like cardiovascular breakdown and renal infections is expanding across the globe. Constant kidney sickness is another significant medical condition. Ascend in accessibility of prescriptions for persistent infection/conditions in these drug stores, simplicity of openness, and development in chain of retail drug stores providing meds for furosemide are other key factors prone to help the development of the market. Expansion in mindfulness about administration of aspiratory edema among heart patients, ascend in pervasiveness of cardiovascular sicknesses, and appeal for drugs in mobile careful focuses.

Furosemide Market – Introduction

Furosemide is a medication used to reduce edema (extra fluid in the body) due to diseases/conditions such as kidney disease, heart disease, and liver disease. It is also used for the treatment of high blood pressure. Furosemide is sulfamoylanthranilic acid derivative. It is also known as diuretic and is primarily administered orally or intravenously. The injectable or intravenous form is used when the drug cannot be administered orally, especially in patients with chronic diseases. The medication helps the kidneys eliminate unneeded water and salt from the body through urine. It blocks the absorption of sodium, chloride, and water from the fluid in the kidneys. However, furosemide carries many side effects such as dehydration, low blood pressure, and electrolyte depletion. The medication reduces symptoms such as shortness of breath, and swelling of arms, legs, and abdomen.

Request for TOC @


Furosemide Market – Competitive Landscape

Key players operating in the global furosemide market are Sanofi, Pfizer Inc., Mylan N.V., Emcure Pharmaceuticals, Sun Pharmaceutical Industries Ltd., SteriMax, and Sandoz Canada Inc.

Mylan N.V.

Mylan N.V. is a pharmaceutical company offering generic and branded medications and serves regions including North America, Europe and Rest of World.  The company operates in 140 countries across the globe. The company offers furosemide tablets indicated in adults and pediatric patients for the treatment of edema associated with cirrhosis of the liver, congestive heart failure and renal disease.

Pfizer Inc

Pfizer is a global pharmaceutical company manufacturing includes medicines and vaccines and consumer health care products. The company leading supplier of high-quality, difficult-to-manufacture, injectable pharmaceutical and surgical products. Pfizer Inc. offers furosemide injection, solution indicated as adjunctive therapy in acute pulmonary edema and for for the treatment of edema.


Sanofi is a pharmaceutical company engaged in the development, production, and sale of pharmaceuticals and health care products for diabetes, cardiovascular, central nervous system, thrombosis, internal medicine, vaccines, and oncology. Sanofi offers LASIX, furosemide oral solution.

Furosemide Market – Dynamics

Furosemide is indicated for the treatment of edema associated with congestive heart failure, chronic renal failure & other diseases. Rise in prevalence of chronic diseases, increase in number of generic drug manufacturers for furosemide, and growth in number of surgical procedures are expected to drive the furosemide market during the forecast period. Additionally, increase in number of promising drugs in pipeline is anticipated to boost the market during the forecast period

Increase in prevalence of chronic disease

The prevalence of chronic diseases such as heart failure and renal diseases is increasing across the globe. As per the Centre for Disease Control and Prevention (CDC), in the U.S., nearly 5.7 million adults had heart failure in 2016 and half of people with heart failure die within 5 years of diagnosis. According to Emory Healthcare, in the U.S., 550,000 new cases are diagnosed each year. Diabetes and obesity key contributors to rising number of patients with heart failure

Chronic kidney disease is another major health problem. More than 661,000 Americans have kidney failure. According to National Institute of Diabetes and Digestive and Kidney Diseases, more than 661,000 Americans have kidney failure, out of which 468,000 patients are on dialysis, and 193,000 patient live with a functioning kidney transplant. Nearly 47,000 Americans died from kidney disease in 2013.

Pre Book Furosemide Market Report at


Product recalls to restrain market growth

Voluntary product recall by pharmaceutical companies, and Food and Drug Administration (FDA) and other regulatory authorities is estimated to restrain the market. For instance, in February 2017, Roxane Laboratories Inc recalled 6493 bottles of Furosemide Tablets USP, 20 mg, available with prescription after a complaint about an unusually thick tablet. In October 2015, the company recalled 16,270 bottles of tablets of diuretic furosemide as per the FDA Enforcement Report. The recall was initiated, as the tablets were manufactured using Active Pharmaceutical Ingredient (API) intended for the oral-suspension version of the drug.

Furosemide market dominated by North America

North America is projected to account for the major share of the market in the near future owing to the increase in number of specialty care services for cardiac and kidney patients, and rise in demand for furosemide in health care institutes. Furthermore, rise in availability of medications for chronic disease/conditions in these pharmacies, ease of accessibility, and growth in chain of retail pharmacies supplying medications for furosemide are other key factors likely to support the growth of the market in North America

Asia Pacific market to grow at rapid pace

The market in Asia Pacific is estimated to expand at a faster pace than that in other regions during the forecast period, led by the increase in awareness about management of pulmonary edema among cardiac patients, rise in prevalence of cardiac diseases, and high demand for drugs in ambulatory surgical centers. Additionally, the increase in number of surgical centers and voluntary organizations conducting workshops & programs, rise in focus on adopting strategies for preventive care are likely to boost the growth of the market in the region.

More Trending Reports by Transparency Market Research –

Intravascular Ultrasound Devices Market:


Bromelain Market:


About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!


Transparency Market Research,

90 Sate Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Comments are closed